Quantessence Capital’s Ocugen OCGN Stock Holding History

Quantessence Capital’s Portfolio OCGN Stock Details OCGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-25,952	Closed	-$47K	–	114
2026 Q1	$47K	Buy	+25,952	New	+$44.9K	0.23%	57
2025 Q3	–	Sell	-200,783	Closed	-$195K	–	271
2025 Q2	$195K	Buy	+200,783	New	+$167K	0.06%	165

Other funds holding OCGN

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Ikarian Capital Dallas, Texas $928M AUM 596.14% 1-Year Est. Return

GMT Capital Atlanta, Georgia $1.92B AUM 70.51% 1-Year Est. Return

Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return

Quantessence Capital's OCGN Position: Q2 2026 in Review

Quantessence Capital sold out of Ocugen (OCGN) in Q2 2026, closing a stake of 25,952 shares — an estimated $47K sold.

Quantessence Capital first reported a position in OCGN in Q2 2025 and held it in 2 quarters. The position peaked at $195K in Q2 2025. 147 funds tracked by Wall St. Rank hold OCGN as of Q2 2026.

Quantessence Capital reported no remaining Ocugen position as of Q2 2026 after selling out during the quarter.
Quantessence Capital sold 25,952 Ocugen shares in Q2 2026, an estimated $47K.
Quantessence Capital first reported a position in Ocugen in Q2 2025 and held it in 2 quarters.
Quantessence Capital's Ocugen position peaked at $195K in Q2 2025.
147 funds tracked by Wall St. Rank held Ocugen as of Q2 2026.

Based on Quantessence Capital's 13F filing for Q2 2026, filed 14 Aug 2026.